Reed Elsevier PLC
25 August 2004
25 August 2004
ISSUED ON BEHALF OF REED ELSEVIER PLC AND REED ELSEVIER NV
Director Shareholding
Reed Elsevier announces that on 23 August 2004, Erik Engstrom, who was appointed
as an executive director on that date of Reed Elsevier PLC and Reed Elsevier
Group plc, was granted (for no monetary consideration) the following options and
awards:
(a) An option equivalent in value to 5.5 times his annual salary
comprising an option to acquire 265,332 shares in Reed Elsevier PLC (PLC Shares)
at an exercise price of 478p per share and 183,408 shares in Reed Elsevier NV
(NV Shares) at an exercise price of €10.30 per share under the Reed Elsevier
Long Term Incentive Share Option Scheme (the LTIS) and a further option to
acquire 53,066 PLC Shares and 36,682 NV Shares on the same terms and at the same
prices as the options granted under the LTIS;
(b) An award of conditional shares equivalent in value to 2.5
times his annual salary comprising nil cost options to acquire 120,605 PLC
Shares and 83,367 NV Shares under the LTIS and a further award to acquire 24,121
PLC Shares and 16,673 NV Shares on the same terms as the conditional share award
granted under the LTIS.
These options and conditional shares will vest after three years, subject to the
achievement of EPS performance of Reed Elsevier PLC and Reed Elsevier NV during
2004-2006 and to the Rules of the Scheme. Awards will vest on a sliding scale,
determined by the averaged adjusted compound growth in EPS over the three year
performance period. There will be no re-testing of the three year EPS
performance. If EPS growth is less than 8% per annum then none of the awards
will vest; if EPS is 8% per annum 25% of the award will vest; if EPS is 10% per
annum 100% of the award will vest; and if EPS is 12% per annum 125% of the award
will vest. Awards will vest on a straight line basis between each of these
points. The options will be exercisable until 2014 and the conditional shares
for three months after vesting.
(c) An option to acquire 63,460 PLC shares at an exercise price
of 478p per share and 43,866 NV Shares at an exercise price of €10.30 per share
under the Reed Elsevier Group plc Share Option Scheme. Subject to the
achievement of 6% per annum compound growth in the averaged adjusted EPS of Reed
Elsevier PLC and Reed Elsevier NV during the three years 2004-2006 and, subject
to the Rules of the Scheme, these options will vest after three years and will
be exercisable until 2014. There will be no re-testing of the three year EPS
performance;
(d) A nil cost restricted share award of 115,781 PLC Shares and
80,032 NV Shares (having an aggregate value of US$2,000,000) without performance
targets. The award vests in three annual instalments commencing on 23 August
2005 and is subject to forfeiture in the event that Mr Engstrom leaves the
Company other than in specified circumstances.
The further option and conditional share award, granted outside the LTIS,
described in (a) and (b) above are designed to ensure that Mr Engstrom is put in
an equivalent position to other executive directors who received awards of
options and conditional shares under the LTIS in February 2004. The
Remuneration Committee considered that these were appropriate and necessary to
secure Mr Engstrom's recruitment. The Remuneration Committee also considered
that the restricted share award described in (d) above was appropriate and
necessary to secure Mr Engstrom's recruitment by compensating him for the loss
of profit participation that he suffered on leaving his previous employer to
join Reed Elsevier. These awards fall within paragraph 13.13A of the Listing
Rules (special arrangements to facilitate the recruitment of an executive
director) and, consequently, shareholder's approval was not required. The
shares required to satisfy these awards will be provided by the Reed Elsevier
Employee Benefit Trust.
Contact
Catherine May: +44 (0)20 7166 5674
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.